Taiwan (TW)

Broadband Adiabatic Couplers in Thin-Film Lithium Niobate on Insulator (2021) Lin YX, Younesi M, Chung HP, Chiu HK, Geiss R, Tseng QH, Setzpfandt F, et al. Conference contribution Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? (2021) Park J, Choi JY, Choi J, Chung S, Song N, Park SK, Han W, et al. Journal article Do cultural norms influence how teacher noticing is studied in different cultural contexts? A focus on expert norms of responding to students’ mathematical thinking (2021) Dreher A, Lindmeier A, Feltes P, Wang TY, Hsieh FJ Journal article Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium (2021) Morra A, Jung AY, Behrens S, Keeman R, Ahearn TU, Anton-Culver H, Arndt V, et al. Journal article Periodic poling with a micrometer-range period in thin-film lithium niobate on insulator (2021) Younesi M, Geiss R, Rajaee S, Setzpfandt F, Chen YH, Pertsch T Journal article Martensite-austenite transition correlated twinning and symmetry breaking in single crystalline Ni50Mn35In15 (2021) Chen YS, Lin JG, Singh S, Manna K, Fecher GH, Felser C Journal article Stabilizing Effect of Polysulfides on Lithium Metal Anodes in Sparingly Solvating Solvents (2021) Reuter FS, Huang CJ, Hsieh YC, Doerfler S, Brunklaus G, Althues H, Winter M, et al. Journal article Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor plus (HR plus ) metastatic breast cancer (MBC) who have previously received a taxane (2021) O'Shaughnessy J, Schwartzberg L, Piccart M, Rugo HS, Yardley DA, Cortes J, Untch M, et al. Conference contribution Treatment-related amenorrhea with T-DM1 plus pertuzumab (KP) is lower than with docetaxel/carboplatin/ trastuzumab/pertuzumab (TCHP) in the phase III neoadjuvant KRISTINE trial (2021) Hurvitz SA, Fresco R, Afenjar K, Stroyakovskiy D, Huang CS, Wildiers H, Jung KH, et al. Conference contribution Global Phase 3 Study of Adagloxad Simolenin (OBI-822) and OBI-821 Versus Placebo Treatment for High Risk Early Stage Triple Negative Breast Cancer Patients (TNBC) Following Neoadjuvant or Adjuvant Chemotherapy (2021) Rugo H, Chow LWC, Cortes J, Fasching P, He XB, Hsu P, Huang CS, et al. Conference contribution